VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357,805 | -19.7% | 13,300 | -10.1% | 0.00% | 0.0% |
| Q2 2023 | $445,773 | -98.6% | 14,800 | -98.5% | 0.00% | -99.0% |
| Q1 2023 | $32,667,256 | +211.9% | 1,009,807 | +176.3% | 0.10% | +259.3% |
| Q4 2022 | $10,473,425 | +4794.1% | 365,437 | +3989.9% | 0.03% | – |
| Q3 2022 | $214,000 | -99.7% | 8,935 | -99.7% | 0.00% | -100.0% |
| Q2 2022 | $76,033,000 | -50.5% | 2,776,994 | -30.7% | 0.18% | -30.7% |
| Q1 2022 | $153,719,000 | +1143.7% | 4,008,327 | +938.6% | 0.26% | +1435.3% |
| Q4 2021 | $12,360,000 | -79.5% | 385,927 | -81.1% | 0.02% | -84.0% |
| Q3 2021 | $60,314,000 | -69.6% | 2,046,627 | -65.0% | 0.11% | -71.0% |
| Q2 2021 | $198,608,000 | +76.0% | 5,844,845 | +68.3% | 0.37% | +65.6% |
| Q1 2021 | $112,845,000 | +48.3% | 3,472,745 | +64.4% | 0.22% | +36.4% |
| Q4 2020 | $76,106,000 | +37.6% | 2,112,882 | +49.5% | 0.16% | +7.3% |
| Q3 2020 | $55,329,000 | +462.6% | 1,412,954 | +427.6% | 0.15% | +344.1% |
| Q2 2020 | $9,835,000 | -35.2% | 267,818 | -59.3% | 0.03% | -34.6% |
| Q1 2020 | $15,183,000 | -85.7% | 658,518 | -81.8% | 0.05% | -79.8% |
| Q4 2019 | $105,899,000 | +25.3% | 3,616,541 | +14.3% | 0.26% | +2.8% |
| Q3 2019 | $84,532,000 | +61.7% | 3,165,050 | -28.2% | 0.25% | +14.6% |
| Q2 2019 | $52,266,000 | -47.9% | 4,407,075 | -1.5% | 0.22% | -44.8% |
| Q1 2019 | $100,288,000 | +318.5% | 4,473,072 | +293.7% | 0.40% | +254.5% |
| Q4 2018 | $23,962,000 | -73.6% | 1,136,195 | -76.8% | 0.11% | -72.2% |
| Q3 2018 | $90,633,000 | +99.8% | 4,893,803 | +140.7% | 0.40% | +61.8% |
| Q2 2018 | $45,357,000 | +5.8% | 2,033,066 | +4.3% | 0.25% | +12.7% |
| Q1 2018 | $42,861,000 | +18.2% | 1,950,000 | +25.0% | 0.22% | +33.9% |
| Q4 2017 | $36,257,000 | +729.9% | 1,560,093 | +719.9% | 0.16% | +560.0% |
| Q3 2017 | $4,369,000 | +56.4% | 190,272 | +50.9% | 0.02% | +66.7% |
| Q2 2017 | $2,794,000 | -91.6% | 126,111 | -91.4% | 0.02% | -89.4% |
| Q1 2017 | $33,363,000 | -9.6% | 1,462,621 | -17.1% | 0.14% | -24.9% |
| Q4 2016 | $36,915,000 | +89.6% | 1,764,588 | +139.5% | 0.19% | +71.8% |
| Q3 2016 | $19,471,000 | +3.0% | 736,736 | +7.9% | 0.11% | -0.9% |
| Q2 2016 | $18,909,000 | – | 682,636 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |